Literature DB >> 16092502

Intracellular trafficking of HIV-1 Gag: how Gag interacts with cell membranes and makes viral particles.

Marilyn D Resh1.   

Abstract

The Gag polyprotein of retroviruses and lentiviruses is the master orchestrator of viral particle formation. HIV-1 Gag is synthesized on cytosolic polysomes where it is co-translationally modified with the 14-carbon fatty acid myristate. New findings shed light on how myristoylated HIV-1 Gag traffics through the cell, binds to specific membranes, and assembles into virions. The affinity of Gag for membrane bilayers is regulated by a myristoyl switch; Gag multimerization induces the fatty acid to flip away from the protein, thereby promoting membrane binding during assembly. Several recent studies have shown that newly synthesized Gag traffics first to multivesicular bodies (MVB), endosomal compartments that contain protein complexes necessary for particle budding. Signals within Gag, as well as specific host-cell lipids and proteins, promote MVB localization. In macrophages, Gag is retained in MVBs; viral particles are formed within the MVB lumen and released from the cell via exocytosis. In other cell types, Gag and/or MVBs rapidly transit to the plasma membrane where particle release occurs. Given that MVB exocytosis is an essential host-cell pathway, effective antiviral agents will need to specifically target interaction of Gag with the endocytic pathway without perturbing the normal host-cell trafficking network.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16092502

Source DB:  PubMed          Journal:  AIDS Rev        ISSN: 1139-6121            Impact factor:   2.500


  42 in total

Review 1.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 2.  Function of a retrotransposon nucleocapsid protein.

Authors:  Suzanne B Sandmeyer; Kristina A Clemens
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  Ty3 nucleocapsid controls localization of particle assembly.

Authors:  Liza S Z Larsen; Nadejda Beliakova-Bethell; Virginia Bilanchone; Min Zhang; Anne Lamsa; Rhonda Dasilva; G Wesley Hatfield; Kunio Nagashima; Suzanne Sandmeyer
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  Probing the structural states of human immunodeficiency virus type 1 pr55gag by using monoclonal antibodies.

Authors:  Jason J Leblanc; Omar Perez; Thomas J Hope
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

5.  Ty3 capsid mutations reveal early and late functions of the amino-terminal domain.

Authors:  Liza S Z Larsen; Min Zhang; Nadejda Beliakova-Bethell; Virginia Bilanchone; Anne Lamsa; Kunio Nagashima; Rani Najdi; Kathryn Kosaka; Vuk Kovacevic; Jianlin Cheng; Pierre Baldi; G Wesley Hatfield; Suzanne Sandmeyer
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

6.  Fluorescence fluctuation spectroscopy on viral-like particles reveals variable gag stoichiometry.

Authors:  Yan Chen; Bin Wu; Karin Musier-Forsyth; Louis M Mansky; Joachim D Mueller
Journal:  Biophys J       Date:  2009-03-04       Impact factor: 4.033

Review 7.  The structural biology of HIV assembly.

Authors:  Barbie K Ganser-Pornillos; Mark Yeager; Wesley I Sundquist
Journal:  Curr Opin Struct Biol       Date:  2008-04-09       Impact factor: 6.809

Review 8.  New insights into HIV assembly and trafficking.

Authors:  Muthukumar Balasubramaniam; Eric O Freed
Journal:  Physiology (Bethesda)       Date:  2011-08

9.  Insulin-like growth factor II mRNA binding protein 1 associates with Gag protein of human immunodeficiency virus type 1, and its overexpression affects virus assembly.

Authors:  Yongdong Zhou; Liwei Rong; Jennifer Lu; Qinghua Pan; Chen Liang
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

10.  The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.

Authors:  Sandrina Dafonseca; Pascale Coric; Bernard Gay; Saw See Hong; Serge Bouaziz; Pierre Boulanger
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.